What to do when a smoker's CT scan is "normal"? Implications for lung cancer screening

Chest

Volumn 141, Issue 5, 2012, Pages 1147-1152

  Zurawska, Joanna H ^a   Jen, Rachel ^a   Lam, Stephen ^a,b   Coxson, Harvey O ^a   Leipsic, Jonathon ^a   Sin, Don D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE MARKER; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; LUNG CANCER; LUNG EMPHYSEMA; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK MANAGEMENT; SMOKING; SPIROMETRY; THORAX RADIOGRAPHY;

EID: 84860565595     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1863     Document Type: Note

References (25)

1. Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J Thorac Oncol. 2008;3(8):819-831.
2. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
3. Black WC. Cost effectiveness of screening in the National Lung Screening Trial, 2011. National Cancer Institute Web site. http://deainfo.nci.nih.gov/ advisory/ncab/158-0611/ presentations/1230dBlack.pdf. Accessed September 26, 2011.
4. Dutch Belgian randomised lung cancer screening trial (NELSON). NELSON Web site. http://www.nelsonproject.nl/. Accessed September 26, 2011.
5. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax. 2005;60(7):570-575. (Pubitemid 40966211)
6. Calabrò E, Randi G, La Vecchia C, et al. Lung function predicts lung cancer risk in smokers: a tool for targeting screening programmes. Eur Respir J. 2010;35(1):146-151.
7. Tammemagi MC, Lam SC, McWilliams AM, Sin DD. Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res (Phila). 2011;4(4):552-561.
8. Alberg AJ, Ford JG, Samet JM; American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed). Chest. 2007;132(suppl 3):29S-55S. (Pubitemid 47502798)
9. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med. 2009;15(4):303-307.
10. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med. 2008;359(13):1367-1380.
11. Schwartz AG, Ruckdeschel JC. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173(1):16-22. (Pubitemid 43069784)
12. Lambrechts D, Buysschaert I, Zanen P, et al. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. Am J Respir Crit Care Med. 2010;181(5):486-493.
13. Wauters E, Smeets D, Coolen J, et al. The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema. Eur Respir J. 2011;38(4):924-931,
14. de Torres JP, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest. 2007;132(6):1932-1938.
15. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178(7):738-744.
16. Mizuno S, Takiguchi Y, Fujikawa A, et al. Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology. 2009;14(3):377-383.
17. Maldonado F, Bartholmai BJ, Swensen SJ, Midthun DE, Decker PA, Jett JR. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest. 2010;138(6):1295-1302.
18. Li Y, Swensen SJ, Karabekmez LG, et al. Effect of emphysema on lung cancer risk in smokers: a computed tomography-based assessment. Cancer Prev Res (Phila). 2011;4(1):43-50.
19. Wilson DO, Leader JK, Fuhrman CR, Reilly JJ, Sciurba FC, Weissfeld JL. Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the Pittsburgh lung screening study. J Thorac Oncol. 2011;6(7):1200-1205.
20. Gietema HA, Müller NL, Fauerbach PV, et al; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol. 2011;18(6):661-671.
21. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697-722.
22. Goddard PR, Nicholson EM, Laszlo G, Watt I. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33(4):379-387. (Pubitemid 12081355)
23. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst. 2011;103(13): 1058-1068.
24. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst.2003;95(6):470-478. (Pubitemid 36432421)
25. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007;99(9):715-726. (Pubitemid 47073532)